Product Comparison


  Allergan Pharmaceutical 00023965201 Greenstone Limited 59762033302

No Image

Allergan Pharmaceutical 00023320503 Allergan Pharmaceutical 00023361670
McKesson # 1178025 772707 944706 742745 874309
Description DURYSTA™ Bimatoprost 10 mcg Intracameral Implant Single-Use Applicator 1 Implant Latanoprost 0.005%, 50 mcg / mL Solution Dropper Bottle 2.5 mL Latisse® Bimatoprost 0.03% Solution Dropper Bottle 5 mL Lumigan® Bimatoprost 0.01% Solution Dropper Bottle 2.5 mL Latisse® Bimatoprost 0.03% Solution Dropper Bottle 3 mL
Manufacturer # 0002396520159762033302000233616050002332050300023361670
Brand DURYSTA™ Latisse®Lumigan®Latisse®
Manufacturer Allergan PharmaceuticalGreenstone LimitedAllergan PharmaceuticalAllergan PharmaceuticalAllergan Pharmaceutical
Invoice DURYSTA, SNGL-USE APPL 10MCG D/S (2EA MIN)LATANOPROST, DRP 125MCG/2.5ML 2.5MLLATISSE, DRP OPHTH W/APPL 0.03% 5ML 9ALGNLUMIGAN, DRP OPHTH 0.01% 2.5MLL 9ALGNLATISSE, DRP OPHTH W/APPL 0.03% 3ML 9ALGN
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 15508961805308142590918930802067767
Container Type Single-Use ApplicatorDropper BottleDropper BottleDropper BottleDropper Bottle
Country of Origin CanadaUnknownCanadaCanadaCanada
Dosage Form Intracameral ImplantSolutionSolutionSolutionSolution
Generic Drug Code 32749162192713116219
Generic Drug Name BimatoprostLatanoprostBimatoprostBimatoprostBimatoprost
NDC Number 0002396520159762033302000233616050002332050300023361670
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Quantity 1 Implant
Storage Requirements Requires RefrigerationRequires Refrigeration
Strength 10 mcg0.005%, 50 mcg / mL0.03%0.01%0.03%
UNSPSC Code 5124110351241110512411035124110351241103
Volume 2.5 mL5 mL2.5 mL3 mL
Application Prostaglandin AnalogProstaglandin AnalogProstaglandin AnalogProstaglandin AnalogProstaglandin Analog
Type OphthalmicOphthalmicOphthalmicOphthalmicOphthalmic
Features and Benefits
  • DURYSTA is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT)
  • DURYSTA contains a 10 mcg bimatoprost intracameral implant in a single-use applicator that is packaged in a sealed foil pouch containing desiccant
  • For ophthalmic intracameral administration
  • Latanoprost is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
  • Topical eyelash solution with 140 applicators
  • LUMIGAN® is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension
  • Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours
  • Topical eyelash solution with 70 applicators